← Back to headlines
Bausch + Lomb Advances Dry Eye Drops to Phase 3 Trials
Bausch + Lomb is moving its dual-action dry eye drops into phase 3 clinical trials, marking a significant step in the development of the new treatment.
24 Aug, 21:19 — 24 Aug, 21:19
Sources
Showing 1 of 1 sources
